[go: up one dir, main page]

WO2010077061A3 - 항바이러스성 약물을 포함하는 약제학적 제제 - Google Patents

항바이러스성 약물을 포함하는 약제학적 제제 Download PDF

Info

Publication number
WO2010077061A3
WO2010077061A3 PCT/KR2009/007880 KR2009007880W WO2010077061A3 WO 2010077061 A3 WO2010077061 A3 WO 2010077061A3 KR 2009007880 W KR2009007880 W KR 2009007880W WO 2010077061 A3 WO2010077061 A3 WO 2010077061A3
Authority
WO
WIPO (PCT)
Prior art keywords
antiviral drugs
pharmaceutical formulations
drugs
formulations containing
containing antiviral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2009/007880
Other languages
English (en)
French (fr)
Other versions
WO2010077061A2 (ko
Inventor
김성욱
전성수
이아람
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hanall Biopharma Co Ltd
Original Assignee
Hanall Biopharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanall Biopharma Co Ltd filed Critical Hanall Biopharma Co Ltd
Publication of WO2010077061A2 publication Critical patent/WO2010077061A2/ko
Publication of WO2010077061A3 publication Critical patent/WO2010077061A3/ko
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

본 발명은 항바이러스성 약물 및 지연방출물질을 포함하는 약제학적 제제와 사이토크롬 P450 관련 약물을 포함하는 선방출성 구획, 및 항바이러스성 약물 및 지연방출물질을 포함하는 지연방출성 구획을 포함하는 약제학적 제제를 제공하며, 본 발명의 제제는 항바이러스성 약물의 상호작용을 감소시켜 약효를 증가시키고 부 작용을 감소시킬 수 있다는 장점을 갖는다.
PCT/KR2009/007880 2008-12-31 2009-12-29 항바이러스성 약물을 포함하는 약제학적 제제 Ceased WO2010077061A2 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14198308P 2008-12-31 2008-12-31
US61/141,983 2008-12-31

Publications (2)

Publication Number Publication Date
WO2010077061A2 WO2010077061A2 (ko) 2010-07-08
WO2010077061A3 true WO2010077061A3 (ko) 2010-11-04

Family

ID=42310377

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/007880 Ceased WO2010077061A2 (ko) 2008-12-31 2009-12-29 항바이러스성 약물을 포함하는 약제학적 제제

Country Status (1)

Country Link
WO (1) WO2010077061A2 (ko)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030099706A1 (en) * 2000-10-13 2003-05-29 Rudnic Edward M. Antiviral product, use and formulation thereof
US20060003005A1 (en) * 2004-07-02 2006-01-05 Bruce Cao Tablet for pulsed delivery
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
US20060204578A1 (en) * 2001-11-06 2006-09-14 Vergez Juan A Dual controlled release dosage form
KR100824547B1 (ko) * 1995-06-29 2008-11-04 아보트 러보러터리즈 사이토크롬p450에의해대사되는약물의약력학을개선하기위한리토나비르(abt-538)의용도

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100824547B1 (ko) * 1995-06-29 2008-11-04 아보트 러보러터리즈 사이토크롬p450에의해대사되는약물의약력학을개선하기위한리토나비르(abt-538)의용도
US20030099706A1 (en) * 2000-10-13 2003-05-29 Rudnic Edward M. Antiviral product, use and formulation thereof
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
US20060204578A1 (en) * 2001-11-06 2006-09-14 Vergez Juan A Dual controlled release dosage form
US20060003005A1 (en) * 2004-07-02 2006-01-05 Bruce Cao Tablet for pulsed delivery

Also Published As

Publication number Publication date
WO2010077061A2 (ko) 2010-07-08

Similar Documents

Publication Publication Date Title
WO2009111653A3 (en) Antiviral therapeutic agents
WO2010036407A3 (en) Antiviral nucleoside analogs
WO2010000877A3 (en) Formulation with irritation reducing action comprising bisabolol and [6]-paradol
WO2008132229A3 (en) Highly concentrated insulin solutions and compositions
WO2010077740A3 (en) Novel antiviral compounds, compositions, and methods of use
WO2011051971A3 (en) Solid dispersion of rifaximin
MX2010010407A (es) Derivados de 4-aminociclohexanos sustituidos.
WO2007086001A3 (en) Novel pyridine derivatives
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
WO2009117130A3 (en) Extended release forumulation containing a wax
WO2009121039A3 (en) Administration of benzodiazepine compositions
IL210549A (en) Pipedrine - Quinocosalin-Mediated Conjugated Drugs
WO2009115084A3 (de) Pyrrolopyrimidin-derivate und deren verwendungen
WO2008017346A3 (de) Ascorbinsäurederivate, verwendung zur funktionalisierung von matrices
WO2010021607A3 (en) Pharmaceutical formulation
WO2011009938A3 (en) Stambomycin and derivatives, their production and their use as drugs
TW200942530A (en) Pyridine compounds
WO2009135593A3 (de) Feste arzneimittelformulierung mit verzögerter freisetzung
WO2011054837A3 (de) Bifunktionale prodrugs und drugs
WO2010046061A3 (de) Kosmetische und/oder pharmazeutische zubereitungen
WO2010049449A3 (en) Novel salts of sunitinib
TN2009000510A1 (en) Extended release formulation of nevirapine
WO2010065586A3 (en) Preparation of capecitabine
WO2009026257A8 (en) Methods and compositions for controlling the bioavailability of poorly soluble drugs
MX344189B (es) Formulaciones de mazindol.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09836382

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09836382

Country of ref document: EP

Kind code of ref document: A2